Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

WAYNESBORO HOSPITAL

NPI: 1821091059 · WAYNESBORO, PA 17268 · Clinic/Center · NPI assigned 05/23/2005

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official BUCZKOWSKI, LAURA controls 11+ related entities in our dataset. Read more

$1.48M
Total Medicaid Paid
41,223
Total Claims
38,314
Beneficiaries
71
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialBUCZKOWSKI, LAURA (SR VP AND CFO)
NPI Enumeration Date05/23/2005

Related Entities

Other providers sharing the same authorized official: BUCZKOWSKI, LAURA

ProviderCityStateTotal Paid
OUR LADY OF BELLEFONTE HOSPITAL INC ASHLAND KY $12.13M
THE CHAMBERSBURG HOSPITAL CHAMBERSBURG PA $10.29M
VNA HOME HEALTH SERVICES YORK PA $3.99M
WAYNESBORO HOSPITAL FAYETTEVILLE PA $831K
THE CHAMBERSBURG HOSPITAL CHAMBERSBURG PA $801K
WELLSPAN SURGERY AND REHABILITATION HOSPITAL YORK PA $399K
OUR LADY OF BELLEFONTE HOSPITAL INC ASHLAND KY $200K
WAYNESBORO HOSPITAL WAYESBORO PA $11K
THE CHAMBERSBURG HOSPITAL CHAMBERSBURG PA $6K
THE CHAMBERSBURG HOSPITAL CHAMBERSBURG PA $198.19
WAYNESBORO HOSPITAL WAYNESBORO PA $6.58

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 16 $12K
2019 72 $1K
2020 4,321 $137K
2021 21,139 $737K
2022 6,580 $247K
2023 6,541 $252K
2024 2,554 $93K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 2,849 2,675 $506K
99283 Emergency department visit for the evaluation and management, moderate severity 3,090 2,947 $324K
99284 Emergency department visit for the evaluation and management, high severity 1,991 1,852 $252K
74177 Computed tomography, abdomen and pelvis; with contrast material 422 406 $73K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,375 1,276 $37K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 468 447 $32K
80053 Comprehensive metabolic panel 3,087 2,922 $29K
0202U Oncology (prostate), multianalyte, gene expression profiling 102 102 $27K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4,266 4,023 $20K
99282 Emergency department visit for the evaluation and management, low to moderate severity 358 344 $18K
96375 Therapeutic injection; each additional sequential IV push 867 808 $16K
70450 Computed tomography, head or brain; without contrast material 242 229 $15K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,280 1,209 $15K
96361 Intravenous infusion, hydration; each additional hour 951 886 $11K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 989 920 $8K
84702 517 492 $8K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 129 125 $7K
36415 Collection of venous blood by venipuncture 2,130 1,911 $7K
84484 757 689 $5K
71045 Radiologic examination, chest; single view 753 715 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 112 96 $5K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 177 169 $5K
71275 Computed tomographic angiography, chest, with contrast material 24 24 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 72 68 $4K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 137 119 $4K
81001 1,385 1,317 $4K
83690 726 680 $3K
87086 Culture, bacterial; quantitative colony count, urine 426 400 $3K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 232 225 $3K
T1015 Clinic visit/encounter, all-inclusive 58 19 $2K
85730 423 389 $2K
87040 99 92 $2K
85379 180 170 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 202 168 $2K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 281 264 $2K
85610 553 480 $1K
71046 Radiologic examination, chest; 2 views 97 95 $1K
80076 203 188 $1K
J2270 Injection, morphine sulfate, up to 10 mg 561 504 $1K
83605 191 175 $1K
80051 210 194 $1K
82565 215 200 $983.45
96376 27 25 $867.48
J7030 Infusion, normal saline solution , 1000 cc 1,303 1,192 $849.83
84520 214 198 $838.84
82947 279 248 $809.65
73610 39 39 $764.17
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 12 12 $684.80
73630 56 55 $639.57
84443 Thyroid stimulating hormone (TSH) 37 37 $533.01
J1885 Injection, ketorolac tromethamine, per 15 mg 2,393 2,138 $484.14
80048 Basic metabolic panel (calcium, ionized) 64 62 $451.69
83735 133 106 $451.69
87077 56 55 $383.31
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,070 1,874 $379.74
80061 Lipid panel 29 27 $347.20
J1100 Injection, dexamethasone sodium phosphate, 1 mg 664 635 $310.36
83880 12 12 $237.13
87186 29 28 $234.40
86140 62 57 $155.85
83036 Hemoglobin; glycosylated (A1C) 28 27 $128.31
81025 25 25 $89.00
82248 12 12 $67.91
86901 17 17 $61.51
86900 17 17 $60.77
J0696 Injection, ceftriaxone sodium, per 250 mg 104 101 $28.84
81003 21 20 $26.36
A9270 Non-covered item or service 28 12 $15.55
J1200 Injection, diphenhydramine hcl, up to 50 mg 230 198 $14.14
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 29 27 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 46 44 $0.00